Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease

BACKGROUND: Diabetes is the commonest cause of chronic kidney disease (CKD). Both conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes and CKD make glucose‐lowering challenging, increasing the risk of hypoglycaemia. Glucose‐lowering agents have been mainly studied...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cochrane Database Syst Rev
Prif Awduron: Lo, Clement, Toyama, Tadashi, Wang, Ying, Lin, Jin, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel M, Pilmore, Helen, Badve, Sunil V, Perkovic, Vlado, Zoungas, Sophia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Ltd 2018
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513625/
https://ncbi.nlm.nih.gov/pubmed/30246878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011798.pub2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg